{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"Natera, Inc."},"Symbol":{"label":"Symbol","value":"NTRA"},"Address":{"label":"Address","value":"13011 MCCALLEN PASS,BUILDING A SUITE 100, AUSTIN, Texas, 78753, United States"},"Phone":{"label":"Phone","value":"+1 650 249-9090"},"Industry":{"label":"Industry","value":"Medical Specialities"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"Natera Inc is operative in the healthcare field in the United States. Its core business is to offer invasive and other means of diagnosing the genetic features of a fetus. Natera's array of diagnostic services includes Panorama Non-Invasive Prenatal Test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, Anora Products of Conception (POC) test to analyze fetal chromosomes to understand the cause of miscarriage, and Non-Invasive Paternity Testing (PAT), to determine paternity by studying the fragments of fetal deoxyribonucleic acid (DNA) in a pregnant mother's blood and a blood sample from the alleged father. The Company acquires its revenue by billing an insurance carrier, a clinic, or a patient for the test upon delivery of the test result."},"CompanyUrl":{"label":"Company Url","value":"https://www.natera.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Alexey Aleshin","title":"Chief Medical Officer"},{"name":"Eric A. Evans","title":"Chief Scientific Officer"},{"name":"Rishi Kacker","title":"Chief Technology Officer"},{"name":"Robert A. Schueren","title":"Chief Operating Officer"},{"name":"Stephen Chapman","title":"Chief Executive Officer & Director"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}